These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 27402308)
1. Rac3 regulates cell proliferation through cell cycle pathway and predicts prognosis in lung adenocarcinoma. Wang G; Wang H; Zhang C; Liu T; Li Q; Lin X; Xie J; Liu H Tumour Biol; 2016 Sep; 37(9):12597-12607. PubMed ID: 27402308 [TBL] [Abstract][Full Text] [Related]
2. Silencing of Rac3 inhibits proliferation and induces apoptosis of human lung cancer cells. Liu TQ; Wang GB; Li ZJ; Tong XD; Liu HX Asian Pac J Cancer Prev; 2015; 16(7):3061-5. PubMed ID: 25854406 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of Long Non-Coding RNA ZXF2 Promotes Lung Adenocarcinoma Progression Through c-Myc Pathway. Yang ZT; Li Z; Wang XG; Tan T; Yi F; Zhu H; Zhao JP; Zhou XF Cell Physiol Biochem; 2015; 35(6):2360-70. PubMed ID: 25896422 [TBL] [Abstract][Full Text] [Related]
4. MARCH9 Suppresses Lung Adenocarcinoma Progression by Downregulating ICAM-1. Shen QM; Wang HY; Xu S Cell Physiol Biochem; 2018; 50(1):92-107. PubMed ID: 30278450 [TBL] [Abstract][Full Text] [Related]
5. MACC1 silencing inhibits cell proliferation and induces cell apoptosis of lung adenocarcinoma cells through the β-catenin pathway. Guo L; Ou S; Ma X; Zhang S; Lai Y Neoplasma; 2018; 65(4):552-560. PubMed ID: 29940751 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas. Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423 [TBL] [Abstract][Full Text] [Related]
7. NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma. Zhan P; Xi GM; Zhang B; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu Q; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Lv TF; Song Y J Cell Mol Med; 2017 Apr; 21(4):665-676. PubMed ID: 27862966 [TBL] [Abstract][Full Text] [Related]
8. Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma. Qiao Y; Chen J; Ma C; Liu Y; Li P; Wang Y; Hou L; Liu Z Cell Physiol Biochem; 2018; 51(1):1-10. PubMed ID: 30439711 [TBL] [Abstract][Full Text] [Related]
9. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma. Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875 [TBL] [Abstract][Full Text] [Related]
10. Silencing Aurora-A with siRNA inhibits cell proliferation in human lung adenocarcinoma cells. Zhong N; Shi S; Wang H; Wu G; Wang Y; Ma Q; Wang H; Liu Y; Wang J Int J Oncol; 2016 Sep; 49(3):1028-38. PubMed ID: 27571708 [TBL] [Abstract][Full Text] [Related]
11. PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway. Zhan P; Zhang B; Xi GM; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu QQ; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Qian LP; Lv TF; Song Y Mol Cancer; 2017 Jun; 16(1):108. PubMed ID: 28646916 [TBL] [Abstract][Full Text] [Related]
12. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression. Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741 [TBL] [Abstract][Full Text] [Related]
13. HIST1H3D: A promising therapeutic target for lung cancer. Rui Y; Peng WJ; Wang M; Wang Q; Liu ZL; Chen YQ; Huang LN Int J Oncol; 2017 Mar; 50(3):815-822. PubMed ID: 28112369 [TBL] [Abstract][Full Text] [Related]
15. Rac3 Regulates Cell Invasion, Migration and EMT in Lung Adenocarcinoma through p38 MAPK Pathway. Zhang C; Liu T; Wang G; Wang H; Che X; Gao X; Liu H J Cancer; 2017; 8(13):2511-2522. PubMed ID: 28900489 [No Abstract] [Full Text] [Related]
16. Induction of microRNA‑let‑7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1. Zhao W; Hu JX; Hao RM; Zhang Q; Guo JQ; Li YJ; Xie N; Liu LY; Wang PY; Zhang C; Xie SY Oncol Rep; 2018 Oct; 40(4):1843-1854. PubMed ID: 30066899 [TBL] [Abstract][Full Text] [Related]
17. β-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells. Yu W; Li L; Zheng F; Yang W; Zhao S; Tian C; Yin W; Chen Y; Guo W; Zou L; Deng W Cell Physiol Biochem; 2017; 44(2):467-478. PubMed ID: 29141249 [TBL] [Abstract][Full Text] [Related]
18. C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells. Xie C; Pan Y; Hao F; Gao Y; Liu Z; Zhang X; Xie L; Jiang G; Li Q; Wang E APMIS; 2014 Dec; 122(12):1251-8. PubMed ID: 25131138 [TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of N-myc downregulated gene 1 in lung adenocarcinoma. Dai T; Dai Y; Murata Y; Husni RE; Nakano N; Sakashita S; Noguchi M Pathol Int; 2018 Apr; 68(4):224-231. PubMed ID: 29431240 [TBL] [Abstract][Full Text] [Related]
20. MID1-PP2A complex functions as new insights in human lung adenocarcinoma. Zhang L; Li J; Lv X; Guo T; Li W; Zhang J J Cancer Res Clin Oncol; 2018 May; 144(5):855-864. PubMed ID: 29450633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]